Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma
Nurit Gal-Mark, Galina Feinberg‐Gorenshtein, Valid Gahramanov, Michal Hameiri-Grossman, Elena Shinderman-Maman, Dafna Gaas, Keren Shichrur, Jaques Mordoukh, Nino Oniashvili, Eva Chausky Barzakh, Aviv Sever, Shirah Amar, Shifra Ash, Yehudit Birger, Shai Izraeli, , Esther R. Berko
This paper develops a mutation-independent liquid biopsy method using DNA methylation to monitor high-risk neuroblastoma through blood plasma-derived cfDNA.
Clinical Cancer Research · Jul 1, 2026Peer-reviewedCancer Biology